IP Library › Granted Patent US 11,639,360
Granted Patent B2
US 11,639,360 · App. 17/053,042 · Granted May 2, 2023

Oxazine compound and application thereof

Inventors: Jiangli Fan (Liaoning, CN); Qichao Yao (Liaoning, CN); Haidong Li (Liaoning, CN); Yana Bian (Liaoning, CN); Mingle Li (Liaoning, CN); Jingyun Wang (Liaoning, CN); Xiaojun Peng (Liaoning, CN)
Assignees: DALIAN UNIVERSITY OF TECHNOLOGY; DALIAN CHROMAS BIOSCIENCE CO., LTD
C07D517/16A61K9/14A61K41/0033A61K41/0057A61P35/00C07D513/16C09K11/06G01N21/6428C09K2211/1018G01N2021/6439
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,639,360
App. No.
17/053,042
Granted
May 2, 2023
Kind
B2
Abstract

Disclosed are an oxazine compound and an application thereof. The oxazine compound has a structure of a general formula F. The oxazine compound described in the disclosure is a photo/acoustic dynamic active organic molecule with near-infrared absorption-emission function as well as photosensitivity and acoustic sensitivity. Maximum absorption and emission wavelengths of the compound are both greater than 660 nanometers, and a triplet-state conversion rate of the compound is high; and under illumination or ultrasound, the compound can produce reactive oxygen species with high efficiency, which has a good killing effect on cancer cells and cancer tissues, and almost has no toxic or side effects on normal tissues while achieving photo/acoustic dynamic therapy on tumors.

Claims (21)

1. An oxazine compound having a structural formula F:

wherein,

A is selenium;

R 1 , R 2 , and R 3 are each independently selected from hydrogen, substituted C 1-20 alkyl, and unsubstituted C 1-20 alkyl;

the substituted C 1-20 alkyl is substituted by one or more functional groups selected from halogen, hydroxyl, alkoxy, aldehyde, carbonyl, amino, carboxyl, ester, acylamino, nitro, and sulfonic acid group; and

X is selected from phosphate radical, sulfate, bisulfate, nitrate, chlorine anion, bromine anion, iodine anion, and perchlorate.

2. The oxazine compound according to claim 1 , wherein R 1 , R 2 , and R 3 are each independently selected from hydrogen, substituted C 1-14 alkyl, and unsubstituted C 1-14 alkyl.

3. The oxazine compound according to claim 2 , wherein R 1 , R 2 , and R 3 are each independently selected from hydrogen, substituted C 1-6 alkyl, and unsubstituted C 1-6 alkyl.

4. The oxazine compound according to claim 3 , wherein one of R 1 and R 2 is hydrogen.

5. The oxazine compound according to claim 3 , wherein R 3 is hydrogen.

6. The oxazine compound according to claim 1 , wherein the compound is selected from

7. A photosensitizer, comprising the oxazine compound according to claim 1 .

8. The photosensitizer according to claim 7 , wherein the photosensitizer sensitizer is a near-infrared long-wavelength fluorescent probe.

9. The photosensitizer according to claim 8 , wherein the photosensitizer comprising self-assembled nanoparticles having particle sizes of 1 to 1000 nanometers.

10. A method for inhibiting growth of cancer cells, comprising:

activating the photosensitizer of claim 7 using a 660-wavelength red light to generate singlet oxygen; and

exposing the cancer cells to the singlet oxygen.

11. An acoustic sensitizer, comprising the oxazine compound according to claim 1 .

12. The acoustic sensitizer according to claim 11 , comprising self-assembled nanoparticles having particle sizes of 1 to 1000 nanometers.

13. A method for inhibiting growth of cancer cells, comprising:

activating the acoustic sensitizer of claim 11 using ultrasound to generate singlet oxygen; and exposing the cancer cells to the singlet oxygen.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2021
From: FAN, JIANGLI; YAO, QICHAO; LI, HAIDONG; BIAN, YANA; LI, MINGLE; WANG, JINGYUN; PENG, XIAOJUN
To: DALIAN UNIVERSITY OF TECHNOLOGY; DALIAN CHROMAS BIOSCIENCE CO., LTD
Reel/Frame 054885/0523 →
Priority Claims (1)
CN 201810420618.1 · May 4, 2018 · national
Continuity (1)
Related Publication 20210188875A1 · Jun 24, 2021
Cited By (2)
US 12,623,094 US 12,741,161